For NAFLD complicated with T2DM, the use of vitamin E, pioglitazone, glucagon-like peptide-1 receptor agonists (GLP-1RAs), and sodium–glucose cotransporter-2 (SGLT2) inhibitors are recommended as a drug therapy [8]. Here, SLC5A2 is linked to metabolic dysfunction-associated steatotic liver disease.